Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Study of Memantine Hydrochloride for the Treatment of Prostate Cancer Patients

NCT07164794 is registered in ClinicalTrials.gov with Bin Xu as lead sponsor.

NCT NCT07164794
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07164794 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Study of Memantine Hydrochloride for the Treatment of Prostate Cancer Patients
Lead sponsor
Bin Xu
Phase
Phase 2
Overall status
Not yet recruiting
Start date
November 30, 2025
Completion date
June 30, 2028
Enrollment
15 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic castration-resistant prostate cancer (mcrpc), neuroendocrine prostate cancer (nepc), prostate cancer